Canlyniadau Chwilio - Miguel Teodoro Hernández‐Garcia

  • Dangos 1 - 4 canlyniadau o 4
Mireinio'r Canlyniadau
  1. 1
    SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status

    SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status gan Lucía López‐Corral, María Eugenia Sarasquete, Sı́lvia Beà, Ramón García‐Sánz, María‐Victoria Mateos, Luís A. Corchete, José María Sayagués, Eva Garcı́a, Joan Bladé, Albert Oriol, Miguel Teodoro Hernández‐Garcia, Pilar Giraldo, Jesús María Hernández‐Rivas, Marcos González, Jesús María Hernández‐Rivas, Jesús F. San Miguel, Norma C. Gutiérrez

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study

    Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included... gan Juan José Lahuerta, M.V. Mateos, Joaquín Martínez‐López, Carlos Grande, Javier de la Rubia, Laura Rosiñol, Anna Sureda, José García‐Laraña, J Díaz-Mediavilla, Miguel Teodoro Hernández‐Garcia, D. Carrera, Joan Besalduch, Felipe de Arriba, Albert Oriol, Lourdes Escoda, Javier García‐Frade, Concepción Rivas-González, Adrián Alegre, Joan Bladé, Jesús F. San Miguel

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    GEM2017FIT Trial: Induction Therapy with Bortezomib-Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) Versus Carfilzomib, Lenalidomide and Dexamethasone (KRd) Plus/Minus Daratumumab (D), 18 Cycles, Followed By Consolidation and Maintenance Therapy with Lenalidomide and Daratumumab: Phase III, Multicenter, Randomized Trial for Elderly Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients Aged between 65 and 80 Years

    GEM2017FIT Trial: Induction Therapy with Bortezomib-Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) Versus Carfilzomib, Lenalidomide and Dexamethason... gan María‐Victoria Mateos, Bruno Paiva, María Teresa Cedena Romero, Noemí Puig, Anna Maria Sureda Balarí, Albert Oriol, Enrique M. Ocio, Laura Rosiñol, Yolanda González-Montes, Juan Bargay, Esther González García, Miguel Teodoro Hernández Garcia, Angel Ramirez, Alexia Suárez-Cabrera, María‐Jesús Blanchard, Sebastián Garzón, Luis Felipe Casado Montero, Valentín Cabañas Perianes, Jaime Pérez de Oteyza, Mercedes Gironella, Joaquín Martínez‐López, Ana-Isabel Teruel, Pilar Delgado, Elena Prieto, Juan José Lahuerta Palacios, Joan Bladé, Jesús F. San Miguel

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

    Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study gan Fredrik Schjesvold, Meletios Α. Dimopoulos, Sosana Delimpasi, Paweł Robak, Daniel Coriu, Wojciech Legieć, Luděk Pour, Ivan Špıčka, Tamás Masszi, Vadim Doronin, Jiří Minařík, Galina Salogub, Yulia Alekseeva, Antonio Lazzaro, Vladimír Maisnar, Gábor Mikala, Laura Rosiñol, Anna Marina Liberati, Argiris Symeonidis, Victoria Moody, Marcus Thuresson, Catriona Byrne, Johan Harmenberg, Nicolaas A. Bakker, Roman Hájek, María‐Victoria Mateos, Paul G. Richardson, Pieter Sonneveld, Fredrik Schjesvold, Sosana Delimpasi, Paweł Robak, Daniel Coriu, Anna Nikolayeva, Waldemar Tomczak, Luděk Pour, Ivan Špıčka, Meletios Α. Dimopoulos, Tamás Masszi, Vadim Doronin, Jiří Minařík, Galina Salogub, Yulia Alekseeva, Vladimír Maisnar, Gábor Mikala, Laura Rosiñol, Т. С. Константинова, Antonio Lazzaro, Anna Marina Liberati, Argiris Symeonidis, Moshe E. Gatt, Árpád Illés, Haifaa Abdulhaq, Moez Dungarwalla, Sebastian Grosicki, Roman Hájek, Xavier Leleu, Alexander Myasnikov, Paul G. Richardson, Irit Avivi, Dries Deeren, Mercedes Gironella, Miguel Teodoro Hernández‐Garcia, Joaquín Martínez‐López, Muriel Newinger-Porte, Paz Ribas, Olga Samoilova, Éric Voog, Mario Arnao‐Herráiz, Estrella Carrillo‐Cruz, Paolo Corradini, Jyothi Dodlapati, Miquel Granell, Shang‐Yi Huang, Matthew Jenner, Lionel Karlin, Jin Seok Kim, Agnieszka Kopacz, Н. В. Медведева, Chang‐Ki Min, Roberto Mina, Katrin Palk, Ho‐Jin Shin, Sang Kyun Sohn, Pieter Sonneveld, Jason Tache, Αchilles Anagnostopoulos, José-María Arguiñano, Michèle Cavo, Joanne Filicko, Margaret Garnes, Janusz Hałka, Kathrin Herzog-Tzarfati, Natalia Ipatova, Kihyun Kım, Maria‐Theresa Krauth, I. V. Kryuchkova, Mihaela Lazaroiu, Mario Luppi, Andrei Proydakov, Alessandro Rambaldi

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: